{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Wang Z"],"funding":["National High Technology Research and Development Program of China","Kaifeng Municipal Science and Technology Research and Development Project","Beijing Physician Scientist Training Project","Henan Provincial Science and Technology Research and Development Project","the Natural Science Foundation of Beijing, China"],"pagination":["e70971"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12759265"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["30(1)"],"pubmed_abstract":["Aortic dissection is a life-threatening cardiovascular emergency with limited pharmacological options. This study focuses on elucidating the multi-target and multi-pathway mechanisms through which morusin mitigates aortic dissection progression, integrating network pharmacology, single-cell transcriptomics and experimental validation. Multi-database analysis identified 281 morusin targets and 1741 ad-related genes, with 84 overlaps. Enrichment analyses highlighted IL-17, HIF-1 and MAPK signalling pathways as potential regulatory hubs. Protein-protein interaction network analysis identified seven key targets, all showing high binding affinity to morusin in molecular docking. Single-cell transcriptomics revealed cell-type-specific dysregulation, notably MAPK8 upregulation in fibroblasts and immune cells. In vitro, morusin dose-dependently inhibited AngII-induced vascular smooth muscle cell proliferation and modulated IL-17 pathway gene expression. In vivo, morusin attenuated aortic dilation and reduced morbidity and mortality in a BAPN-induced AD mouse model. These findings suggest that morusin mitigates AD progression by targeting key inflammatory and apoptotic pathways, supporting its potential as a multi-target therapeutic candidate."],"journal":["Journal of cellular and molecular medicine"],"pubmed_title":["Integrated Network Pharmacology, Single-Cell Transcriptomics Unveil the Mechanistic Role of Morusin in Aortic Dissection."],"pmcid":["PMC12759265"],"funding_grant_id":["BJPSTP-2024-21","NO. 2023YFA1800904","NO.L232031","NO.252102311099","NO.2020YFA0803700","NO.2203023","NO.J230039"],"pubmed_authors":["Niu C","Zhang H","Xie Z","Zheng L","Xiang Y","Fu Y","Jiang C","Wang Z","Jiao H","Lin N"],"additional_accession":[]},"is_claimable":false,"name":"Integrated Network Pharmacology, Single-Cell Transcriptomics Unveil the Mechanistic Role of Morusin in Aortic Dissection.","description":"Aortic dissection is a life-threatening cardiovascular emergency with limited pharmacological options. This study focuses on elucidating the multi-target and multi-pathway mechanisms through which morusin mitigates aortic dissection progression, integrating network pharmacology, single-cell transcriptomics and experimental validation. Multi-database analysis identified 281 morusin targets and 1741 ad-related genes, with 84 overlaps. Enrichment analyses highlighted IL-17, HIF-1 and MAPK signalling pathways as potential regulatory hubs. Protein-protein interaction network analysis identified seven key targets, all showing high binding affinity to morusin in molecular docking. Single-cell transcriptomics revealed cell-type-specific dysregulation, notably MAPK8 upregulation in fibroblasts and immune cells. In vitro, morusin dose-dependently inhibited AngII-induced vascular smooth muscle cell proliferation and modulated IL-17 pathway gene expression. In vivo, morusin attenuated aortic dilation and reduced morbidity and mortality in a BAPN-induced AD mouse model. These findings suggest that morusin mitigates AD progression by targeting key inflammatory and apoptotic pathways, supporting its potential as a multi-target therapeutic candidate.","dates":{"release":"2026-01-01T00:00:00Z","publication":"2026 Jan","modification":"2026-05-28T03:23:45.053Z","creation":"2026-05-28T03:12:45.217Z"},"accession":"S-EPMC12759265","cross_references":{"pubmed":["41482800"],"doi":["10.1111/jcmm.70971"]}}